In our study, the first patient received a suboptimal IS maintenance regimen after LTx, consisting only of steroids and mTOR inhibitor, which are commonly used as both anticancer treatment and IS maintenance regimen in SOT patients, especially after cancer diagnosis.5 Here, MTOR is linked to cancer.